🇺🇸 FDA
Pipeline program

TEMOZOLOMIDE , IRINOTECAN

Phase 2 small_molecule active

Quick answer

TEMOZOLOMIDE , IRINOTECAN for Stage II (pT4)/III colorectal cancer with positive circulating tumor DNA (ctDNA) after oxaliplatin-based adjuvant chemotherapy is a Phase 2 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).

Program details

Company
Fondazione Telethon ETS
Indication
Stage II (pT4)/III colorectal cancer with positive circulating tumor DNA (ctDNA) after oxaliplatin-based adjuvant chemotherapy
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials